<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The EMBO Journal vol.14 no.23 pp.5939-5946, 1995 <br />  <br />  <br /> REG1 binds protein phosphatase type 1 and <br /> regulates glucose repression <span id='am-23' about='obo:NCBITaxon_4930' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4751 obo:NCBITaxon_4893 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_4892 obo:NCBITaxon_4891 obo:NCBITaxon_4890 obo:NCBITaxon_716545 obo:NCBITaxon_2759 obo:NCBITaxon_147537'><span id='am-24' property="rdfs:label" content="Saccharomyces" datatype="xsd:string"></span><span id='am-25'  ></span><span id='am-26' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasAlternativeId" content="NCBITaxon:36915" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasRelatedSynonym" content="Pachytichospora" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Saccharomyces</span> <br /> cerevisiae <br />  <br />  <br /> Jiangling Tu Marian Carlsonl&quot;2                                cycle progression (Durfee et al., 1993; Dohadwala et al., <br />                                                                   1994). Mitotic defects associated with <br /> Integrated Program Cellular Biology, Molecular Biology     mutations PP1 genes <span id='am-30' about='obo:NCBITaxon_4895' typeof='obo:NCBITaxon_33154 owl:Thing obo:NCBITaxon_451864 obo:NCBITaxon_451866 obo:NCBITaxon_147554 obo:NCBITaxon_1 obo:NCBITaxon_4890 obo:NCBITaxon_34346 obo:NCBITaxon_4751 obo:NCBITaxon_131567 obo:NCBITaxon_4894 obo:NCBITaxon_2759'><span id='am-31'  ></span><span id='am-32' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="Schizosaccharomyces" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Schizosaccharomyces</span> pombe <br /> Biophysics Studies, Columbia University, New York, NY 10032   (dis2+1bwsJl sds2J+; Booher Beach, 1989; <br /> lInstitute <span id='am-58' about='obo:NCBITaxon_6754' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_72041 obo:NCBITaxon_33154 obo:NCBITaxon_6681 obo:NCBITaxon_6682 obo:NCBITaxon_6683 obo:NCBITaxon_29964 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_116706 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_6753 obo:NCBITaxon_88770 obo:NCBITaxon_6752'><span id='am-59' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-60' property="rdfs:label" content="Cancer" datatype="xsd:string"></span><span id='am-61'  ></span><span id='am-62' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Cancer</span> Research Departments Genetics     Ohkura et al., 1989; Kinoshita et al., 1990), <span id='am-47' about='obo:NCBITaxon_5052' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_4751 obo:NCBITaxon_131567 obo:NCBITaxon_5042 obo:NCBITaxon_33154 obo:NCBITaxon_147545 obo:NCBITaxon_451864 obo:NCBITaxon_147538 obo:NCBITaxon_4890 obo:NCBITaxon_716546 obo:NCBITaxon_716545 obo:NCBITaxon_1131492 obo:NCBITaxon_451871 obo:NCBITaxon_2759'><span id='am-48' property="rdfs:label" content="Aspergillus" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-50'  ></span><span id='am-51' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasAlternativeId" content="NCBITaxon:37503" datatype="xsd:string"></span>Aspergillus</span> <br /> Development Microbiology, 701 W 168th Street, <br /> HHSC922 Columbia University, New York, NY 10032, USA              nidulans (bimG+; Doonan Morris, 1989) Droso- <br /> 2Corresponding author                                             phila (PPI 87B; Axton et al., 1990). In yeast Saccharo- <br />                                                                   myces cerevisiae, protein phosphatase type 1 encoded <br /> Protein phosphatase type 1 (PP1) encoded GLC7,              GLC7 (DIS2S1), essential gene (Ohkura et al., <br /> an essential gene <span id='am-6' about='obo:NCBITaxon_4932' typeof='owl:Thing obo:NCBITaxon_4930 obo:NCBITaxon_1 obo:NCBITaxon_4751 obo:NCBITaxon_131567 obo:NCBITaxon_4893 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_4892 obo:NCBITaxon_4891 obo:NCBITaxon_4890 obo:NCBITaxon_716545 obo:NCBITaxon_147537 obo:NCBITaxon_2759'><span id='am-7' property="oboInOwl:hasExactSynonym" content="yeast" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasRelatedSynonym" content="Candida robusta" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasExactSynonym" content="brewer&apos;s yeast" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="Saccharomyces cerevisiae" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasExactSynonym" content="baker&apos;s yeast" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces italicus" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasExactSynonym" content="lager beer yeast" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasRelatedSynonym" content="Saccaromyces cerevisiae" datatype="xsd:string"></span><span id='am-17'  ></span><span id='am-18' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces oviformis" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasRelatedSynonym" content="Saccharomyes cerevisiae" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces capensis" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces uvarum var. melibiosus" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasRelatedSynonym" content="Sccharomyces cerevisiae" datatype="xsd:string"></span>Saccharomyces cerevisiae</span>. The                1989; Feng et al., 1991). Like mammalian counterparts, <br /> GLC7 phosphatase required glucose repression               GLC7 protein phosphatase participates regulation <br /> and appears function antagonistically SNF1              diverse processes, including glycogen accumulation <br /> protein kinase. Previously, characterized muta-              sporulation (Feng et al., 1991; Cannon et al., 1994), <br /> tion, gk7-T152K, relieves glucose repression             cell cycle progression (Francisco et al., 1994; Hisamoto <br /> does interfere function GLC7                   et al., 1994; Zhang et al., 1995) protein translation <br /> glycogen metabolism. We proposed mutant                  (Wek et al., 1992). Previously, shown the <br /> GLC7TlS2K phosphatase defective interaction             GLC7 protein phosphatase role regulatory <br /> with regulatory subunit directs participation           mechanism glucose repression, acting antagonistically <br /> PP1 glucose repression mechanism. Here,                 SNF1 protein kinase (Tu Carlson, 1994). Here, <br /> present evidence REG1, protein required                explored role. <br /> glucose repression, regulatory subunit. We                The SNF1 protein kinase required expression of <br /> show REG1 physically associated GLC7.                glucose-repressed genes glucose limiting (Celenza <br /> REG1 interacts GLC7 strongly specifically                Carlson, 1986). SNF1 physically associated a <br /> in two-<span id='am-104' about='obo:NCBITaxon_37965' typeof='owl:Thing obo:NCBITaxon_12908 obo:NCBITaxon_1'><span id='am-105' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-106'  ></span><span id='am-107' property="rdfs:label" content="hybrid" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>hybrid</span> system, REG1 GLC7 fusion                large complex proteins, including SNF4 <br /> proteins co-immunoprecipitate cell extracts.                 activating subunit members <span id='am-44' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-45' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-46' property="rdfs:label" content="family" datatype="xsd:string"></span>family</span> SNF1 - <br /> Moreover, overexpression REG1 fusion protein                 interacting proteins (SIPI, SIP2, GAL83; Yang et al., <br /> suppresses gk7-T152K mutant defect glucose                  1992). Genetic evidence suggests glucose- <br /> repression. <span id='am-63' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-64' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-65'  ></span><span id='am-66' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>This</span> genetic evidence indicate              repressed genes, SNF1 functions relieve transcriptional <br /> that proteins function regulating             repression mediated MIGI, SSN6 TUPI (Nehlin <br /> glucose repression. These results suggest REG1             Ronne, 1990; Keleher et al., 1992; Treitel Carlson, <br /> a regulatory subunit PP1 targets activity           1995). The relationship GLC7 SNF1 protein <br /> proteins glucose repression regulatory pathway.             kinase evident isolated GLC7 gene <br /> Keywords: glucose repression/protein phosphatase 1/regu-           complementation mutation (formerly cidl-226) <br /> latory subunitlSaccharomyces cerevisiae                            partially relieves glucose repression SUC2 <br />                                                                    (invertase) MAL3 (maltase) gene expression (Tu and <br />                                                                    Carlson, 1994). We showed mutation allele <br />                                                                    GLC7, renamed glc7-T152K. Genetic analysis suggests <br /> Introduction                                                       GLC7 protein phosphatase acts antagonistically <br /> The reversible phosphorylation proteins major post-        SNF1 protein kinase glucose repression; various <br /> translational regulatory mechanism eukaryotic cells.            different relationships PP1 SNF1 the <br /> The phosphorylation state protein depends            glucose response mechanism possible. <br /> relative activities protein kinases protein phosphat-          An interesting aspect genetic analysis the <br /> ases. Both kinases phosphatases shown             glc7-T152K allele confers phenotype distinct <br /> play critical roles regulating diverse cellular processes       characterized mutation, glc7-1 <br /> (Hunter, 1987; Cohen, 1989, 1992; Hubbard Cohen,               (Feng et al., 1991; Cannon et al., 1994; Stuart et al., <br /> 1993).                                                              1994). We showed glc7-T152K does impair <br />    One major protein phosphatases                  glycogen accumulation, glc7-1 abolishes glyco- <br /> eukaryotic cells protein phosphatase type 1 (PP1). PPI          gen accumulation does affect glucose repression <br /> is highly conserved, &gt;80% identity yeast              (Tu Carlson, 1994). We proposed glc7-TJ52K <br /> and mammals (Ohkura et al., 1989; Feng et al., 1991)               interferes interaction phosphatase <br /> and participates different cellular regulatory             catalytic subunit regulatory subunit specifically <br /> mechanisms. Mammalian PP1 affects regulation glyco-             directs GLC7 activity target protein(s) involved <br /> gen metabolism, protein synthesis muscle contraction           glucose repression gene expression. <br /> (Cohen, 1989) implicated control cell              In mammalian systems, considerable evidence indicates <br />  <br />    Oxford University Press <br />                                                                                                                           5939 <br />  J.Tu M.Carlson <br />  <br /> that regulatory subunits play major roles controlling       Table I. REGI interacts GLC7 two-hybrid system <br /> PP1 activity specific substrates (Cohen, 1989; <br /> Hubbard Cohen, 1993). Specific regulatory targeting     DNA-binding           Activation            Colora&apos;     1-Gal activityb <br />  subunits direct PP1 catalytic subunit different        hybrid                hybrid                            Glu       Raf <br />  subcellular locations substrates and/or alter regulatory <br /> properties. For example, skeletal muscle, glycogen-     LexA-REG I            GAD                   white       &lt;1        &lt;I <br /> binding (G) regulatory subunit targets catalytic subunit   LexA                  GAD-GLC7              white       &lt;1        &lt;I <br /> to glycogen particles (Cohen, 1989). Such regulatory           LexA-REGI             GAD-GLC7              blue        130       24 <br />                                                                LexA-REG I            GAD-GLC7TI52K         blue         20       10 <br />  subunits conserved mammals yeast. In              LexA-GLC7             GAD-GACI              blue           1      10 <br /> S.cerevisiae, GACI protein a,sequence homolog        LexA-GLC7TI52K        GAD-GACI              blue          2       20 <br />  mammalian G subunit involved activation          LexA-GLC7             GAD-SNF1              white       &lt;1        &lt;1 <br /> glycogen synthase glycogen accumulation (Fran,ois          LexA-REG I            GAD-GACI              white       ND        ND <br />  et al., 1992). Moreover, glycogen accumulation defect     aFour transformants patched selective SC-2% glucose plates, <br />  glc7-1 attributed defect interaction   grown 1 day color transformants determined <br />  mutant PP1 catalytic subunit GACI (Stuart et         filter assay. <br /> al., 1994). Other potential regulators PP1 include GLC8,    bTransformants grown selective SC medium containing either <br />  inhibitor-2 homolog (Cannon et al., 1994), SHPI        4% glucose (Glu, repressing condition) 0.05% glucose plus 4% <br />                                                                raffinose (Raf, derepressing condition). ,B-galactosidase activity is <br />  (Zhang et al., 1995). In S.pombe, sds22 protein           expressed Miller Units. Values averages assays six <br />  associates alters substrate specificity PP1   different transformants. Standard errors &lt;10%. <br /> catalytic subunits encoded dis2+ sds2l+ (Stone          ND, determined. <br />  et al., 1993) genetic evidence supports <span id='am-53' about='obo:NCBITaxon_76236' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_30248 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_33415 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_37572 obo:NCBITaxon_304572 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_127218 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-54'  ></span><span id='am-55' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="Idea" datatype="xsd:string"></span>idea</span> that <br />  sds22 regulates mitotic function PP1 (Ohkura       Results <br />  Yanagida, 1991). The S.cerevisiae homolog EGPI/SDS22 <br />  similar properties (Hisamoto et al., 1995; MacKelvie       REG1 interacts GLC7 two-hybrid <br /> et al., 1995).                                                 system <br />     We sought identify regulatory subunit       To test interaction REG 1 GLC7 <br /> that controls GLC7 function glucose repression          proteins, used two-hybrid (Fields and <br /> regulatory mechanism. The protein encoded REG]              Song, 1989). We expressed hybrid proteins containing <br />  (also called HEX2 SRNI) possible candidate.      LexA fused REG1 GAL4 activation domain <br /> REG] identified negative regulator           (GAD) fused GLC7. Interaction fusion <br /> glucose-repressed genes mutation REG] relieves        proteins vivo monitored activation 3- <br /> glucose repression genes (Entian                   galactosidase expression lexAop-GALI-lacZ target <br /> Zimmermann, 1980; Matsumoto et al., 1983; review           gene (Table I). Strains expressing LexA-REGI and <br /> see Johnston Carlson, 1992). A regi mutation (called       GAD-GLC7 turned blue color assay, control <br /> srnl) identified suppressor mal-],      strains white (Table I). In additional controls, we <br /> affects pre-RNA processing transport (Tung et al.,         did detect blue color transformants expressing <br />  1992); RNA1 homologous human Ran GTPase-                LexA-REG 1 combination GAD-GAC 1 (a <br /> activating protein (Bischoff et al., 1995). A connection       fusion protein <span id='am-68' about='obo:NCBITaxon_79338' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_4130 obo:NCBITaxon_4069 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91888 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71274 obo:NCBITaxon_3193'><span id='am-69'  ></span><span id='am-70' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="Codon" datatype="xsd:string"></span>codon</span> 53; Materials methods) <br /> between GLC7 REG] established             GAD-SIPI (Yang et al., 1992). A GAD-REGl fusion <br /> glc7 (called cidl) reg] alleles isolated         constructed expressed did comple- <br /> search mutants defective glucose repression          ment regi mutation interaction LexA- <br /> SUC2 (Neigebom Carlson, 1987; Tu Carlson,              GLC7 detected (<span id='am-99' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-100'  ></span><span id='am-101' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-102' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-103' property="rdfs:label" content="Data" datatype="xsd:string"></span>data</span> shown). <br />  1994). The glc7-T152K regl-69 alleles isolated             Genetic evidence indicates REG1 function is <br /> this search shown functionally similar           required repression gene expression growth <br /> that snfl epistatic double mutant          glucose. Expression REG] gene regulated <br /> combination showed synergy relieving repression          glucose availability (Niederacher Entian, 1991). <br /> of SUC2. This genetic analysis suggests genes       To test interaction REGI GLC7 <br /> could function glucose repression SUC2.         modulated glucose availability, quantitatively <br /> Therefore, considered REG1 candidate             assayed ,B-galactosidase activity resulting inter- <br /> GLC7 regulatory subunit. REG1 113 kDa protein             action LexA-REG 1 GAD-GLC7 two-hybrid <br /> containing putative nuclear localization signals               glucose-repressing -derepressing <br /> (Niederacher Entian, 1991; Tung et al., 1992).             conditions (Table I). Both proteins expressed from <br />     Here tested model REG1 protein        strong ADHI promoter. In glucose-grown cells, 3- <br /> is associated GLC7 protein phosphatase. We      galactosidase expression stimulated &gt;100-fold <br /> used two-hybrid REGI               (130 U) relative controls. In raffinose-grown cells, <br /> GLC7 interact strongly specifically. We present         3-galactosidase activity substantial (24 U), <br /> biochemical evidence REG1 GLC7 proteins           5-fold lower glucose-repressing condi- <br /> interact physically. Finally, genetic evidence lends   tions. In contrast, cells expressing LexA-GLC7 (Tu <br /> support idea proteins function    Carlson, 1994) GAD-GAC 1, 3-galactosidase <br /> in regulating glucose repression. These data suggest      activity 10-fold higher derepressing conditions. <br /> REGI potential regulatory subunit PPI             These results indicate GLC7 phosphatase interacts <br /> targets activity proteins glucose repression     strongly REG 1 glucose-repressing and <br /> regulatory pathway.                                            derepressing conditions. In addition, possible that <br /> 5940 <br />                                                                                       Yeast protein phosphatase 1 regulatory subunit <br />  <br />  <br /> Table II. Overexpression LexA-REG 1 restores glucose repression      few-fold decreased two-hybrid interaction detected <br /> of SUC2 expression glc7-T152K mutant                               derepressed cells. <br /> Relevant genotype    Expressed protein     Invertase activity           The g/c7-T152K mutation decreases interaction <br />                                            Repressed      Derepressed   GLC7 REG1 <br />                                                                         We proposed glucose repression defect of <br /> glc7-T152K           LexA                   26            250           glc7-TJ52K mutant results defect interaction <br />                      LexA-GLC7               2            220           GLC7Tl12K mutant protein regulatory <br />                      LexA-GLC7TI52K         21            230 <br />                      LexA-REG 1              2            140           subunit (Tu Carlson, 1994). To test defect in <br />                                                                         interaction REG1, used two-hybrid to <br /> reglA::URA3          LexA                  240            230           compare interaction wild-type mutant GLC7 <br />                      LexA-REGI               4             74 <br />                      LexA-GLC7             220            260           proteins LexA-REG1. We expressed derivative <br />                                                                         GAD-GLC7 carrying glc7-TJ52K mutation, called <br /> Invertase activity expressed gmol glucose releasedJmin/100 mg     GAD-GLC7Tls2K. Although reagents that <br /> cells (dry weight). Cultures grown selective SC-2% glucose      detect GAD-GLC7 fusion proteins, evidence <br /> (repressed) shifted SC-0.05% glucose medium 3 h              indicates T152K alteration does affect stability <br /> (derepressed). Values averages transformants of <br /> MCY2616 (glc7-T152K) MCY3278 (reglA::URA3). LexA                protein: LexA fusions mutant wild-type <br /> expressed pLexA(l-202)+PL (Ruden et al., 1991). Standard           GLC7 present level (see below) wild- <br /> errors &lt;20%.                                                       type mutant GLC7-lacZ fusions (Tu Carlson, <br />                                                                         1994) produced P-galactosidase activity (unpub- <br /> the few-fold regulatory effect detected reflects                 lished data). <br /> physiologically significant regulation interaction                  In glucose-grown strains, LexA-REGI combination <br /> between native proteins. However, deter-                mutant GAD-GLC7Tl52K fusion protein produced <br /> mined protein levels affected glucose                    6-fold 0-galactosidase activity LexA-REGI in <br /> induction ADHI promoter.                                         combination wild-type GAD-GLC7 (Table I). These <br />                                                                         findings suggest GLC7Tl52K mutant protein is <br /> REG1 GLC7 fusion proteins co-                                       partially defective interaction REG1 vivo. <br /> immunoprecipitate                                                       Moreover, defect interaction native proteins <br /> To provide biochemical evidence REG1 GLC7                      expressed chromosomal loci probably more <br /> protein phosphatase interact, carried co-immuno-                 severe indicated 6-fold decrease detected <br /> precipitation experiments. Extracts prepared                  overexpression fusion proteins <br /> glucose-grown cells expressing LexA-REG 1                      compensates mutant defect (see below). <br /> HA-GLC7 (Sutton et al., 1991), carries hema-                       In similar experiment, mutant GLC7Tl52K fusion <br /> glutinin (HA) epitope tag. LexA-REG1 complements                      protein showed defect interaction GAC1, the <br /> regi mutation (Table II) HA-GLC7 provides GLC7                      glycogen regulatory subunit PP1 (Table I). This is <br /> function (Stuart et al., 1994). The HA-GLC7 protein                 consistent previous evidence glc7-TJ52K mutant <br /> immunoprecipitated monoclonal HA antibody                      cells accumulate nearly normal levels glycogen. In <br /> the precipitate analyzed Western blotting                contrast, GACI shows defect interaction the <br /> presence LexA-REGI using LexA antibody (Figure                       product glc7-1 allele, reduces glycogen <br /> <span id='am-1' about='obo:NCBITaxon_360966' typeof='owl:Thing obo:NCBITaxon_9397 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_117570 obo:NCBITaxon_32524 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_9431 obo:NCBITaxon_314145 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_30560 obo:NCBITaxon_7776 obo:NCBITaxon_9347'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="Ia" datatype="xsd:string"></span><span id='am-4'  ></span><span id='am-5' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>IA</span>). In addition, LexA-REGI immunoprecipitated                      accumulation (Stuart et al., 1994). Thus, specificity of <br /> with LexA antibody precipitates similarly                  interaction defect correlates phenotype. <br /> analyzed presence HA-GLC7 using HA antibody <br /> (Figure 1 B). In case, REG 1 GLC7 fusion                   Overexpression LexA-REGI suppresses the <br /> proteins co-immunoprecipitated. Control experiments                glc7-T152K mutant defect glucose repression <br /> LexA-SIPI (Yang et al., 1992) HA-SIP4 fusions                       If glucose repression defect glc7-TJ52K mutant <br /> ruled artifactual interactions involving LexA                partial defect interaction PP1 REGI, <br /> HA moieties. In addition, detected protein phosphatase               reasoned increased levels REGI expression <br /> activity (see Figure 3) coprecipitating LexA-REGI                  partially compensate defect therefore <br /> and LexA-SIP1 (data shown). Thus,                       suppress glc7-T152K phenotype. To test possibility <br /> glucose-repressed cells GLC7 protein phosphatase                 introduced pLexA-REG1, expresses fusion <br /> physically associated REGI.                                        protein strong ADHI promoter, glc7- <br />    When extracts prepared derepressed cultures,               T152K mutant assayed invertase activity. Glucose <br /> we able detect co-immunoprecipitation                    repression SUC2 expression restored; fact, the <br /> LexA-REGI HA-GLC7 amounts LexA-                          defect suppressed effectively LexA-REGI as <br /> REGI protein greatly decreased (&gt;20-fold) relative                 LexA-GLC7 (Table II). In contrast, overexpression of <br /> to levels glucose-repressed extracts (data             LexA-GLC7 did suppress reglA defect glucose <br /> shown). However, detected similar amounts LexA-                   repression. These data consistent two-hybrid <br /> REGI repressed derepressed cultures cells                   evidence glc7-TJ52K mutation reduces interaction <br /> were boiled directly gel loading buffer. These                   GLC7 REG 1, suppression LexA- <br /> results, positive two-hybrid results               REGI overexpression accounted other <br /> derepressed cells, suggest LexA-REG1 simply                 mechanisms. Moreover, findings provide additional <br /> stable derepressed extracts. We know              genetic evidence GLC7 REGI function together <br /> this apparent instability related mechanistic level             glucose repression. <br />  <br />                                                                                                                                5941 <br />  J.Tu M.Carlson <br />  <br />                          A               LexA-REG1                           B                       HA-GLC7 <br />                                   HA-GLC7 +    -                                  LexA-REGI           + <br />                                   HA-SIP4 -    +                                  LexA-SIP1           -       + <br />                          IP:     I-X-HA                           220        IP: cif-LexA        &gt; <br />                          Blot:      uf-LexA                                  Blot: (i-HA <br />                                                                                                                    ~~29 <br />                                                                   97 <br />  <br />                          Input <br />                           1t                                  ~~~~22020      Input               &gt;M4         s- <br />  <br />                          Blot: (-f-LexA                                      Blot:    (iX-HA                        29 <br />                                                                   -97 <br />  <br />                                                                   97 <br />                          IP:  (-/-HA                                         IP: c-y-LexA <br />                          Blot: (-a-HA <br />                                                               -   66 <br />                                                                              Blot: ct-LexA <br />                                                               -   46 <br />  <br />  <br />  <br /> Fig. 1. Co-immunoprecipitation LexA-REGI HA-GLC7. Protein extracts (250 gg) prepared glucose-grown wild-type strain <br /> MCY3237 expressing indicated proteins. HA-tagged proteins (A) LexA fusions (B) immunoprecipitated (IP) anti(a)-HA anti(a)- <br /> LexA antibodies, respectively. Precipitated proteins separated SDS-PAGE immunoblotted a-HA a-LexA, indicated to <br /> each panel. Upper panels co-immunoprecipitation LexA-REGI (A) HA-GLC7 (B). Lower panels immunoblot reprobed <br /> with primary antibody confirm precipitation HA-tagged protein (A) LexA fusion (B). Middle panels immunoblots of <br /> the input proteins (25 ,ug). The smaller LexA-REGI <span id='am-73' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-74' property="rdfs:label" content="species" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>species</span> presumably degradation products. HA-SIP4 (98 kDa; gift P.Lesage) and <br /> LexA-SIPI (130 kDa; Yang et al., 1992) negative controls. Size standards indicated kDa. Positions LexA-REGl (closed arrows) and <br /> HA-GLC7 (open arrows) marked. <br />  <br />   We assayed invertase expression strains                     Table III. glc7-T152K reglA::URA3 relieve glucose repression <br /> under derepressing conditions (Table II). Overexpression <br /> of LexA-REGI significantly reduced derepression                          Relevant genotype                       Invertase activity <br /> SUC2 expression, suggesting REGI function                                                               Repressed        Derepressed <br /> a negative regulator gene expression glucose- <br /> repressed -derepressed cells.                                           Wild-type                                 2              390 <br />                                                                             reglA::URA3                             320              410 <br /> Genetic analysis regi gkc7-T152K                                     glc7-TJ52K                               53              360 <br />                                                                             glc7-T152K regJA::URA3                  280              370 <br /> To compare phenotypic effects glc7-TJ52K a <br /> regi null allele, constructed set strains               Invertase activity expressed Table II. Strains grown to <br /> genetic background. We introduced reglA::URA3,                      mid-log phase YEP-2% glucose (repressed) shifted YEP- <br /> deletion codons 52-480 (Tung et al., 1992),                       0.05% glucose (derepressed) 2.5 h. Values averages assays <br /> wild-type diploid (see Materials methods). Southern                     different segregants. Standard errors &lt;21%. <br /> blot analysis confirmed disruption. Tetrad analysis of <br /> diploids heterozygous regi disruption showed                        supports view glc7-T152K reglA relieve <br /> 2+:2- segregations growth YEP-2% sucrose con-                        glucose repression pathway. <br /> taining glucose analog 2-DG, indicating                           We reglA glc7-TJ52K cause distinct <br /> disruptants resistant glucose repression SUC2.                    phenotypes respect various processes than <br /> We disrupted REG] locus heterozygous                          glucose repression. First, course tetrad <br /> +/glc7-T152K diploid recovered single mutant                       analysis, noted difference regi glc7- <br /> and glc7-T152K reglA:: URA3 double mutant segregants.                       T152K growth phenotypes. After dissection, glc7- <br />    Mutant segregants assayed invertase activity                    TJ52K spore clones grew normally regi spores <br /> (Table III). The reglA mutation completely relieved                         slow form visible spore clones sub- <br /> glucose repression SUC2, indicating REG]                         sequently showed normal growth. <br /> absolutely required glucose repression regulatory                      Second, assayed mutant strains glycogen <br /> mechanism. In contrast, glc7-TJ52K caused partial                    accumulation using iodine staining method (Figure <br /> release, consistent model glc7-TJ52K reduces                  2). The glc7-TJ52K mutant cells accumulated glycogen <br /> interaction GLC7 REG1, partially                        wild-type, consistent quantitative <br /> impairing repression. The double mutant segregants                          assays (Tu Carlson, 1994) glc7-1 cells were <br /> showed quantitatively similar defects glucose repression                 completely deficient (Fran,ois et al., 1992; Cannon et al., <br /> of SUC2 expression reglA single mutants; additive                     1994). The reglA mutant cells deficient, sug- <br /> effect synergy observed (Table III). The similarity                  gesting reglA does cause general defect in <br /> between single double mutant phenotypes                     PP1 activity. Surprisingly, however, accumulated <br />  <br /> 5942 <br />                                                                                              Yeast protein phosphatase 1 regulatory subunit <br />  <br />  <br />  <br />                    S                      ~~~~glc7-1                       I-- <br />  <br />  <br />  <br />  <br />                                              WT                            a) <br />  <br />                                                                            E <br />                                              reg 1A::URA3 <br />                                                                            :I <br />  <br />                                              gic7-T1 52K <br />                                                                                         1       2    3     4               1       2    3     4 <br /> Fig. 2. Glycoeen acCL umuLlmation mutltants wild-type. Yeast <br /> Colonics wcrc patched onito YEP-2&quot; g(ILIucOSC plates. incubated 30W-C                    GLC7     GLC7Tl52K                 GLC7     GLC7T152K <br /> f&apos;Or 24 h stalined iodinc vapor. Strains JC782.24D                            LexA Fusion Protein                LexA Fusion Protein <br /> (Oc7-/). 1FY2(5 (wild-type. W&apos;T). MICY3278 (rcoJ1A..:lR.43) and <br />                                                                            Fig. 3. Protein phosphatase activity immunoprecipitated wxild-type <br />                                                                            mutanit GLC7 fusion protein. Protein extracts (&gt;0 pgT) were <br />                                                                            prepared f&apos;rom glucose-grown transformiiants wIldts p .str.in FY250) <br />                                                                            expressing LexA-GLC7 LexA-GLC7T] -K, indicated. <br />  clvcoen somewhat higher levels wild-type.                 The     Transformants carried pRS424 sector (bairs 3) or <br /> basis enhanced accumulation clear                  (see    pRJ85 (REGI pRS424) (bars 2 4). LexA fusions were <br /> Discussioni).                                                              imminuLinoprecipitated anti-LexA antibod. (A) Phosphatase assays <br />    Finally. diploids homozygous reugIA sporulated                      immiiiiunoprecipitate beads performiied using - <br />                                                                            phosphorylase a1s substrate. (B) Immunoprecipitates first <br /> efficientlN, diploids homozygous gic7-T152K                      treated Co2-/trypsin stimulate phosphatasesactitittv (see <br /> were defective, previously shown (Neigebom                          Materials methods) assaved. Two transformanllts ot&apos; each <br /> Carl-son. 1 987). This dramatic phenotypic difference sug-                 type assayed. I mmunoblot analvsis saiamples used for <br /> gests possibility gic7-T152K affects                    bars aind 3 showed wild-type mutant fusions expressed <br /> aspect ot GLC7 function independent REGI.                       levels. In addition. transformants expressing LexA-GLC7 <br />                                                                            GAD-GACI assayed values simillar for <br /> for examiiple, interaction regulatory protein             transformants carrvitg multicopy REG I plasmid. Bars represent <br /> or intrinsic   enzymatic actiNlity.                                    phosphataise activity -&apos;P c.p.m. released assay. Standaird <br />                                                                            deviations indicated. <br /> LexA-GLC7Tl52K partially defective for <br /> phosphatase activity vitro                                              hybrid \x e showed LexA-REG I GAD- <br /> Genetic e-vidence argues drastic overall reduction               GLC7 interact i.n tito. We demonstrated LexA- <br /> in activity otf mutant GLC7Tl&apos;-K phosphatase: gl(7-                    REGI HA-GLC7 fusion proteins co-immunoprecipi- <br /> T152K mutants normal growth glycogen                              tate cell extracts. Finally, genetic analysis indicates <br /> accun]ulation. null mutants inviable gic 7-1               REGI GLC7 function affect glucose <br /> mutants fail accumulate glycogen. However, different                    repression. Mutations genes relieve glucose repres- <br /> cellular   processes  different thresholds sensi-              sion double mutant combination causes synergy <br /> tivity&apos; PPI activitv sporulation particularly              additive effect. Morev,er, overexpression REGI <br /> sensitive impairment     PPI activity. Therefore.                 fusion protein effectiv ely suppresses glucose repression <br /> assayed protein phosphatase activity mutant                     defect caused glc7-T152K. These findings support the <br />  wYild-type LexA fusion proteins. Immunoblot analysis                      model REG I regulatory subunit GLC7 that <br /> showved fusions expressed                       directs PPI activity targets glucose repression <br /> levels (data shown) displayed expected                    pathway. <br /> functional behaviors vi1&apos;0 (Table II). Proteins                       Mutation REGI relieves glucose repression most <br /> immllunoprecipitated w,ith LexA antibody pre-                      genes tested, including SUC2, MAL3. <br /> cipitates assayed protein phosphatase activity                    GAL], ADH2, HXT2, HXT4 mitochondrial genes <br /> using 32P-labeled phosphorylase substrate (Figure 3A).                  (Entian Zimmermann, 1980; Matsumato et al., 1983; <br /> Precipitates assayed treatment cobalt                 Neigebom Carlson, 1987; Dombek et ail., 1993; Ulery <br /> chloride plus trypsin. followed addition trypsin                     et Cal., 1994: Ozcan Johnston. 1995): genes encoding <br /> inhibitor stimulates protein phosphatase activity                    gluconeogenic enzymes exceptions (Entian and <br /> (Feng et cil., 1991) (Figure 3B). Activity mutant                   Zimmermann, 1980). This major loss glucose repression <br /> LexA-GLC7TI52K w&apos;as lower LexA-GLC7                        explained absence regulatory subunit <br /> these titro assays. sueaestina unfused                         mediates effects GLC7 phosphatase on <br /> GLC7TI&apos; K protein probably reduced phosphatase                         glucose repression. The glcZ7-T152K mutation causes more <br /> activity relative wild-type protein ini vitO.                       limited defects; example. glc 7-T152K does relieve <br />                                                                            glucose repression GAL] promoter (Neigebom and <br /> Discussion                                                                 Carlson, 1987) ADH2 (Dombek et Cal., 1993) only <br />                                                                            partially relieves repression SUC2. We suggest that <br /> Here present genetic biochemical evidence                      gl(7-T152K causes partial functional defect and <br /> the REG I protein physically functionally associated                requirement GLC7-REG 1 function glucose <br /> with GLC7 type I protein phosphatase. Usine two-                   repression stringent genes for <br />  <br />                                                                                                                                             5943 <br />  J.Tu M.Carlson <br />  <br />  others. Thus, glc7-T152K causes phenotypic effect       Table IV. List Saccharomyces cerevisiae strains <br />  subset genes repression sensitive <br />  GLC7-REG1 function.                                         Straina        Genotype <br />      Genetic evidence, two-hybrid and <br />  overexpression studies, consistent idea   MCY835     MATa glc7-T152K lys2-801 ura3-52 <br />                                                                 MCY1093    MATa his4-539 lys2-801 ura3-52 <br />  partial glucose repression defect glc7-TJ52K mutant       MCY2616    MATa glc7-T152K his3A200 lys2-801 trplAl ura3-52 <br />  results decreased interaction REGI            MCY2649    MATa his3A200 leu2-3,112 trplAJ ura3-52 <br />  GLC7Tl52K. It possible Thrl52 participates          MCY2921    MATa ade2-101 his3A200 trpJAl ura3-52 <br />  specific protein-protein contact REGI            MCY3263    MATa glc7-T152K reglA::URA3 ade2-101 trpJAl <br />  disrupted mutation Lys. However, mutation                 ura3-52 <br />                                                                 MCY3268 MATa reglA::URA3 ade2-101 lys2-801 trpJAl ura3-52 <br />  effects GLC7 function, judged           MCY3278 MATa reglA::URA3 his3A200 leu2AJ trpJA63 ura3-52 <br />  sporulation defect glc7-T152K mutants,         JC782.24Db MATa glc7-1 lys2 leu2 met4 ura3 <br />  shared regi mutants, decreased phosphatase       FY250C     MATa reglA::URA3 his3A200 leu2AJ trpJA63 ura3-52 <br />  activity LexA-GLC7Tl52K protein vitro. Thus,         CTY10-5dd MATa gal4 gal80 URA3::1exAop-lacZ ade2-101 <br />  exclude possibility presence Lys                    his3A200 leu2AJ trpIA901 <br />  position 152 alters conformation GLC7            aMCy strains S288C background carry SUC2. <br />  indirectly impairs interaction REG1. Interest-    bObtained J.Cannon. <br />  ingly, glc7-1 mutation analogous properties    cObtained F.Winston; S288C genetic background. <br />  impairs interaction GACI regulatory subunit        dConstructed R.Sternglanz (SUNY, Stony Brook). <br />  causes major defect glycogen metabolism but <br />  associated pleiotropic phenotypes (Feng et al.,       regulatory subunits for <br />  1991; Wek et al., 1992; Cannon et al., 1994; Francisco         association GLC7; REGI absent, greater <br />  et al., 1994).                                                 proportion cellular pool PPl associated <br />     Two key questions remain open regarding role         GAC 1. A second possibility mutation REG] <br />  GLC7-REG1 glucose repression. First,           causes various physiological changes indirectly result <br />  targets phosphatase activity glucose repression      enhanced glycogen accumulation. For example, the <br />  mechanism? Previous genetic evidence suggests             glucose repression defect regl mutants cause <br />  GLC7 functions antagonistically SNF1 protein            glycogen accumulation commence earlier stage <br />  kinase phosphorylation SIPI altered immune       growth curve, seen glc7-TJ52K mutant <br />  complex assays SNF1 kinase activity glc7-TJ52K         cultures (Tu Carlson, 1994). Finally, enhanced <br />  mutants (Tu Carlson, 1994). In addition, genetic           accumulation reflect effects regi GACI <br />  evidence (Erickson Johnston, 1993) suggested inter-        expression. <br />  action REGI GAL83, protein associa-           REG] shown affect processes that <br /> ted SNF1 kinase complexes (Yang et al., 1994).             examined glc7-T152K mutants. For <br /> Thus, regulators SNF1, substrates SNF1 SNF1        example, regi impairs glucose induction HXTJ (glucose <br /> kinase itself potential candidates targets GLC7-     transporter) gene expression (Ozcan Johnston, 1995). <br /> REGI activity.                                                  In addition, reglA suppresses mutations affect pre- <br />     The second question function REG1         RNA processing transport (Tung et al., 1992); this <br /> or GLC7-REG1 complex, regulated response           case, likely GLC7 involved because <br /> glucose availability. It shown expression      mammalian PP1 implicated mRNA processing <br /> the REG] gene glucose-regulated (Niederacher         (Mermoud et al., 1994). Tung et al. (1992) suggested <br /> Entian, 1991). Interaction REGI PPI fusion          REGI serve connect RNA processing and <br /> proteins two-hybrid appeared regulated      transport carbon source regulation. Alternatively, REGI <br /> a few-fold dramatically; however, fusion          target PP1 activity substrates involved processes <br /> proteins overexpressed remains possible         glucose repression. <br /> the interaction native proteins regulated more <br /> significant extent. Other possible mechanisms include: <br /> regulation ability REGI recognize substrates,      Materials methods <br /> differential localization REGI GLC7-REG1           Strains genetic methods <br /> the cell control phosphatase activity inhibitory    Saccharomyces cerevisiae strains listed Table IV. Standard methods <br /> subunit. Finally, conceivable GLC7-REG1              yeast genetic analysis (Rose et al., 1990) transformation (Ito <br /> activity regulated response glucose availability   et al., 1983) followed. 2-Deoxyglucose (2-DG) resistance was <br />                                                                 tested YEP (1% yeast extract, 2% bacto-peptone) containing 2% <br /> but function regulated differential availability   sucrose 200 gg/mI 2-DG (Sigma) anaerobic conditions with <br /> phosphorylated substrate proteins.                              Gas Paks (BBL). Control plates lacked 2-DG. Scoring performed <br />     In addition common effects glucose repres-      spotting cell suspensions solid medium. Selective synthetic <br /> sion, glc7-TJ52K reglA mutations cause distinct         complete medium (SC) used grow strains carrying <span id='am-109' about='obo:NCBITaxon_36549' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-110' property="oboInOwl:hasAlternativeId" content="NCBITaxon:2435" datatype="xsd:string"></span><span id='am-111' property="rdfs:label" content="plasmids" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span>plasmids</span>. To <br /> phenotypes. The sporulation defect glc7-T152K mutants        assess sporulation proficiency, diploid cells grown YEP-2% <br />                                                                 glucose plates overnight, patched sporulation medium (Rose et al., <br /> may result decreased enzymatic activity                 1990), incubated room temperature 8 days examined <br /> GLC7T152K loss interaction regu-        microscopically presence asci. <span id='am-76' about='obo:NCBITaxon_562' typeof='owl:Thing obo:NCBITaxon_561 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_91347 obo:NCBITaxon_1224 obo:NCBITaxon_2 obo:NCBITaxon_543 obo:NCBITaxon_1236'><span id='am-77' property="oboInOwl:hasDbXref" content="PMID:10319482" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662101" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli commune" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-81' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662104" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasRelatedSynonym" content="Escherchia coli" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasExactSynonym" content="Escherichia/Shigella coli" datatype="xsd:string"></span><span id='am-84' property="rdfs:label" content="Escherichia coli" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasRelatedSynonym" content="bacterium E3" datatype="xsd:string"></span><span id='am-87'  ></span><span id='am-88' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasRelatedSynonym" content="Eschericia coli" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasRelatedSynonym" content="Bacillus coli" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasRelatedSynonym" content="Enterococcus coli" datatype="xsd:string"></span>Escherichia coli</span> strain XLl- <br /> latory subunit directs PP1 function sporulation.        Blue used host plasmids. <br /> The enhanced glycogen accumulation observed regi <br /> mutants accounted possible       Construction plasmids <br />                                                                 To construct GLC7 fusions, designed primers amplify the <br /> mechanisms. First, REGI GAC1 compete               entire GLC7 coding region (codons 1-312) introduce BamHI <br />  <br /> 5944 <br />                                                                                               Yeast protein phosphatase 1 regulatory subunit <br />  <br /> sites 5&apos; 3&apos; gene. The 5&apos; primer 5&apos;-CGGGATCCAA-                Glycogen assay <br /> GAAATGGACTCA-3&apos; 3&apos; primer 5&apos;-CGGGATCCTTFTTTT-                    Yeast colonies patched YEP-2% glucose plates, incubated at <br /> CTTTCTACCCCC-3&apos;. Using PCR, amplified GLC7 sequence               30&#176;C overnight stained iodine vapor (Chester, 1968). <br /> from pJT18 (Tu Carlson, 1994). The BamHI fragment the <br /> amplified DNA subcloned BamHI site pGADNOT <br /> (Luban et al., 1993) yield pGAD-GLC7. pGAD-GLC7TI52K                  Acknowledgements <br /> constructed replacing Sail (one polylinker site) fragment of <br /> pGAD-GLC7 SalI-XhoI fragment pJTL18TI52K (Tu               We thank R.Jiang, K.T.Arndt, P.Lesage, A.K.Hopper, J.Cannon and <br /> Carlson, 1994).                                                              F.Winston plasmids strains E.M.Reimann providing a <br />    pRJ85, containing REGI gene pRS424 (Sikorski Hieter,           phosphatase assay protocol. This work supported NIH grant <br /> 1989), pLexA-REGl (pRJ65), containing entire REGI coding             GM34095 M.C. <br /> region fused LexA, gifts R.Jiang (this laboratory). To <br /> construct pLexA-REG 1, sequence extending codon 1 REGI          References <br /> the vector sequence 3&apos; cloned gene amplified PCR from <br /> pUCSRNI (Tung et al., 1992). An EcoRI site introduced 5&apos;          Axton,J.M., Dombradi,V., Cohen,P.T.W. Glover,D.M. (1990) One of <br /> coding sequence reaction. The EcoRI-SalI (pUC vector site)              protein phosphatase 1 isoenzymes Drosophila essential for <br /> fragment amplified DNA cloned cognate sites            mitosis. Cell, 63, 33-46. <br /> pLexA(1-202)+PL (Ruden et al., 1991). Next, ClaI-SalI fragment           Bischoff,F.R., Krebber,H., Kempf,T., Hermes,I. Ponstingl,H. (1995) <br /> (ClaI site codon 52) replaced corresponding fragment            Human RanGTPase-activating protein RanGAPl homologue of <br /> from pUCSRN 1, yielding pLexA-REG 1. pHA-GLC7 (CB597), YCpSO                 yeast Rnalp involved mRNA processing transport. Proc. Natl <br /> derivative expressing HA-tagged GLC7, gift K.T.Arndt (Sutton          Acad. Sci. USA, 92, 1749-1753. <br /> et al., 1991). pHA-SIP4 gift P.Lesage (this laboratory).          Booher,R. Beach,D. (1989) Involvement type 1 protein <br /> To disrupt REGI gene, EcoRI-XbaI fragment purified                phosphatase encoded bwsl + fission yeast mitotic control. Cell, <br /> pUCsrnl::URA3 (Tung et al., 1992) used transform (Rothstein,             57, 1009-1016. <br /> 1983) wild-type haploid strain FY250, wild-type diploid strain           Breeden,J. Nasmyth,K. (1985) Regulation HO gene. Cold <br /> MCY1093 X MCY2649 +/glc7-T152K heterozygous diploid strain                  Spring Harbor Symp. Quant. Biol., 50, 643-650. <br /> MCY835 x MCY2921. The resulting allele designated                        Cannon,J.,     Pringle,J.R., Fiechter,A. Khalil,M. (1994) <br /> reglA::URA3.                                                                   Characterization glycogen-deficient glc mutants Saccharomyces <br />     pGAD-GAC I isolated plasmid library fusions           cerevisiae. Genetics, 136, 485-503. <br /> the GAL4 activation domain (GAD) yeast genomic DNA fragments             Celenza,J.L. Carlson,M. (1986) A yeast gene essential for <br /> (Chien et al., 1991 ) two-hybrid screen GLC7-interacting proteins     release glucose repression encodes protein kinase. Science, <br /> (unpublished data). Sequence analysis indicated GAC 1 fused       233, 1175-1180. <br /> GAD residue 53.                                                           Chester,V.E. (1968) Heritable glycogen-storage deficiency yeast and <br />                                                                                 induction ultra-violet light. J. Gen. Microbiol., 51, 49-56. <br /> fi-Galactosidase invertase assays                                        Chien,C.-T., Bartel,P.L., Sternglanz,R. Fields,S. (1991) The two- <br /> To test f-galactosidase expression, transformants patched          hybrid system: method identify clone genes proteins that <br /> selective SC-2% glucose, grown I day, replicated nitrocellulose        interact protein interest. Proc. Natl Acad. Sci. USA, 88, <br /> filters, permeabilized (-70&#176;C 10 min) incubated X-Gal              9578-9582. <br /> overnight (Breeden Nasmyth, 1985). For quantitative assays, glucose-     Cohen,P. (1989) The structure regulation protein phosphatases. <br /> repressed cultures grown mid-log phase YEP selective SC          Annu. Rev. Biochem., 58, 453-508. <br /> medium containing 2% 4% glucose; derepressed cultures         Cohen,P. (1992) Signal integration level protein kinases, protein <br /> grown 4% raffinose plus 0.05% glucose prepared shifting             phosphatases substrates. Trends Biochem. Sci., 17, 408-413. <br /> YEP SC containing 0.05% glucose 2.5 3 h, respectively. P-          Dohadwala,M., da Cruze e Silva,E.F., Hall,F.L., Williams,R.T., <br /> Galactosidase activity assayed permeabilized cells expressed         Carbonaro-Hall,D.A., Nairn,A.C., Greengard,P. Berndt,N. (1994) <br /> in Miller units (Miller, 1972). Invertase activity assayed         Phosphorylation inactivation protein phosphatase I cyclin- <br /> cells (Tu et al., 1993).                                                        dependent kinases. Proc. Natl Acad. Sci. USA, 91, 6408-6412. <br />                                                                              Dombek,K.M., Camier,S. Young,E. (1993) ADH2 expression is <br /> Immunoprecipitation assays                                                      repressed REG 1 independently mutations alter the <br /> Protein extract immunoprecipitation procedures described            phosphorylation yeast transcription factor ADRI. Mol. Cell. <br /> previously (Yang et al., 1992), extraction buffer 50 mM          Biol., 13, 4391-4399. <br /> HEPES [4-(2-Hydroxyethyl)-l-piperazine-ethanesulfonic acid] pH 7.5,          Doonan,J.H. Morris,N.R. (1989) The bimG gene Aspergillus <br /> 100 mM NaCl, 1% Triton X- 100, containing 2 mM phenylmethylsulfonyl             nidulans, required completion anaphase, encodes a <br /> fluoride I mg/ml pepstatin, leupeptin aprotinin             homolog mammalian phosphoprotein phosphatase 1. Cell, 57, <br /> immobilized rProtein A (RepliGen) used. Proteins separated             987-996. <br /> by SDS-PAGE immunoblotted. Primary antibodies anti-LexA             Durfee,T., Becherer,K., Chen,P., Yeh,S., Yang,Y., Kilburn,A.E., Lee,W. <br /> (gift C.Denis) monoclonal HA antibody (12CA5, BabCo).                    Elledge,S.J. (1993) The retinoblastoma protein associates with <br /> Antibodies detected enhanced chemiluminescence ECL                protein phophatase type I catalytic subunit. Genes Dev., 7, 555-569. <br /> reagents (Amersham International).                                           Entian,K.-D. Zimmermann,F.K. (1980) Glycolytic enzymes and <br />                                                                                intermediates      carbon     catabolite   repression   mutants     of <br /> Protein phosphatase assay                                                      Saccharomyces cerevisiae. Mol. Gen. Genet., 177, 345-350. <br /> Phosphatase activity immunoprecipitation assayed measur-       Erickson,J.R. Johnston,M. (1993) Genetic molecular <br /> ing release 32p labeled phosphorylase described            characterization GAL83: interaction similarities other <br /> Feng et al. (1991) following modifications. The immuno-               genes involved glucose repression Saccharomyces cerevisiae. <br /> precipitates 250 .g protein extract washed resuspended         Genetics, 135, 655-664. <br /> with buffer (50 mM imidazole-HCI, pH 7.4, 5 mM EGTA, 2 mM                    Feng,Z., Wilson,S.E., Peng,Z.Y., Schlender,K.K., Reiman,E.M. and <br /> dithiothreitol 0.2 mg/ml BSA). To measure Co2+/trypsin-stimulated          Trumbly,R.J. (1991) The yeast GLC7 gene required glycogen <br /> phosphatase activity, immunoprecipitates pre-incubated                accumulation encodes type I protein phosphatase. J. Biol. Chem., <br /> 0.2 mM CoC12 5 min 30&#176;C incubated trypsin                       266, 23796-23801. <br /> (0.02 mg/ml) 10 min; soybean trypsin inhibitor added         Fields,S. Song,O. (1989) A novel genetic detect protein- <br /> 0.08 mg/ml (Feng et al., 1991). Phosphatase reactions (25 ,ul) contained        protein interactions. Nature, 340, 245-246. <br /> immunoprecipitate beads 60 ,ug protein extract (with      Francisco,L., Wang,W. Chan,C.S.M. (1994) Type 1 protein <br /> Co2+/trypsin treatment) 40 mM imidazole-HCI, pH 7.4, 4 mM                    phosphatase acts opposition Ipll protein kinase regulating <br /> theophylline, 1.6 mM dithiothreitol, 2 mM EGTA, 0.08 mg/ml BSA.                 yeast chromosome segregation. Mol. Cell. Biol., 14, 4731-4740. <br /> Phosphatase reactions initiated adding [32p] phosphorylase           Francois,J., Thompson-Jaeger,S., Skroch,J., Zellenka,U., Spevak,W. and <br /> (-5 lg, 50 000 c.p.m.). After incubation 30&#176;C 10 min, reaction      Tatchell,K. (1992) GACI encode regulatory subunit protein <br /> was terminated addition 35 jt 20% trichloroacetic acid         phosphatase type I Saccharomyces cerevisiae. EMBO J., 11, 87-96. <br /> 32P released supernatant measured.                              Hisamoto,N., Frederick,D.L., Sugimoto,K., Tatchell,K. and <br />  <br />                                                                                                                                                  5945 <br />   J.Tu M.Carlson <br />  <br />    Matsumoto,K. (1995) The EGPl gene positive regulator                  phosphatase required late G progression S phase. Cold <br />    protein phosphatase type 1 growth control Saccharomyces                  Spring Harbor Symp. Quant. Biol., 56, 75-81. <br />    cerevisiae. Mol. Cell. Biol., 15, 3767-3776.                                    Treitel,M.A. Carlson,M. (1995) Repression SSN6-TUPI is <br />  Hisamoto,N., Sugimoto,K. Matsumoto,K. (1994) The Glc7 type I                     directed MIG I, repressor/activator protein. Proc. Natl Acad. Sci. <br />    protein phosphatase Saccharomyces cerevisiae required cell               USA, 92, 3132-3136. <br />    cycle progression G2/M. Mol. Cell. Biol., 14, 3158-3165.                     TuO. Carlson,M. (1994) The GLC7 type 1 protein phosphatase is <br />  Hubbard,M.J. Cohen,P. (1993) On target new mechanism                  required glucose repression Saccharomvces cerevisiae. Mol. <br />    regulation protein phosphorylation. Trends Biochem. Sci., 18,               Cell.  <br /> </body></html>